J.W. Cole Advisors’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,000
Closed -$1.68K 957
2024
Q1
$1.68K Hold
12,000
﹤0.01% 881
2023
Q4
$1.75K Buy
+12,000
New +$1.86K ﹤0.01% 816

Other funds holding GRTX

J.W. Cole Advisors's GRTX Position: Q2 2024 in Review

J.W. Cole Advisors sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 12,000 shares — an estimated $1.68K sold.

J.W. Cole Advisors first reported a position in GRTX in Q4 2023 and held it in 2 quarters. The position peaked at $1.75K in Q4 2023. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

  • J.W. Cole Advisors reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • J.W. Cole Advisors sold 12,000 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $1.68K.
  • J.W. Cole Advisors first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • J.W. Cole Advisors's Galera Therapeutics, Inc. Common Stock position peaked at $1.75K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on J.W. Cole Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.